https://it.marketscreener.com/quotazioni/azione/FULGENT-GENETICS-INC-31452986/attualita/Fulgent-Genetics-Inc-annuncia-i-dati-di-uno-studio-clinico-di-FID-007-di-Fase-1-1b-nel-trattamento-44059032/?utm_source=telegram&utm_medium=social&utm_campaign=share